Generic medications have been trying to site Ozempic for years. And now they have found a shortcut in Canada
Something strange has happened with the patent that protects Ozempic In Canada. By mistake or by strategic decision, Novo Nordisk, the company responsible for developing the semaglutida, the compound on which the popular drug is based has been without paying the maintenance rates of this patent. An error of millions. The surprise jumped a few … Read more